BSC
ADMA icon

BOLTON SECURITIES CORPORATION’s ADMA Biologics ADMA Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17K Buy
+130
New +$2.05K ﹤0.01% 1933
2025
Q3 		$13.6K Buy
+930
New +$15.9K ﹤0.01% 1475
2025
Q1 		$46.9K Buy
+2,363
New +$40.9K ﹤0.01% 1064

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's ADMA Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in ADMA Biologics (ADMA) in Q1 2026: 130 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #1933 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in ADMA as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in ADMA in Q1 2025 and has held it in 3 quarters since. The position peaked at $46.9K in Q1 2025. 360 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 130 shares of ADMA Biologics worth $1.17K as of Q1 2026.
  • ADMA Biologics was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • ADMA Biologics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1933 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in ADMA Biologics in Q1 2025 and has held it in 3 quarters since.
  • BOLTON SECURITIES CORPORATION's ADMA Biologics position peaked at $46.9K in Q1 2025.
  • 360 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.